MKS Instruments Inc (MKSI)vsZepp Health Corp (ZEPP)
MKSI
MKS Instruments Inc
$265.44
-0.92%
TECHNOLOGY · Cap: $17.87B
ZEPP
Zepp Health Corp
$17.47
+4.55%
TECHNOLOGY · Cap: $247.54M
Smart Verdict
WallStSmart Research — data-driven comparison
MKS Instruments Inc generates 1418% more annual revenue ($3.93B vs $258.90M). MKSI leads profitability with a 7.5% profit margin vs -15.5%. MKSI earns a higher WallStSmart Score of 55/100 (C-).
MKSI
Buy55
out of 100
Grade: C-
ZEPP
Hold41
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-43.3%
Fair Value
$180.80
Current Price
$265.44
$84.64 premium
Margin of Safety
+48.6%
Fair Value
$46.70
Current Price
$17.47
$29.23 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
No standout strengths identified
Reasonable price relative to book value
Revenue surging 43.0% year-over-year
Areas to Watch
7.5% margin — thin
Elevated debt levels
Premium valuation, high expectations priced in
Distress zone — elevated risk
Smaller company, higher risk/reward
ROE of -17.2% — below average capital efficiency
Earnings declined 68.1%
Currently unprofitable
Comparative Analysis Report
WallStSmart ResearchBull Case : MKSI
Revenue growth of 10.6% demonstrates continued momentum. PEG of 1.32 suggests the stock is reasonably priced for its growth.
Bull Case : ZEPP
The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.
Bear Case : MKSI
The primary concerns for MKSI are Profit Margin, Debt/Equity, P/E Ratio. A P/E of 60.7x leaves little room for execution misses. Debt-to-equity of 1.76 is elevated, increasing financial risk.
Bear Case : ZEPP
The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.
Key Dynamics to Monitor
MKSI profiles as a value stock while ZEPP is a hypergrowth play — different risk/reward profiles.
MKSI carries more volatility with a beta of 1.90 — expect wider price swings.
ZEPP is growing revenue faster at 43.0% — sustainability is the question.
Monitor SCIENTIFIC & TECHNICAL INSTRUMENTS industry trends, competitive dynamics, and regulatory changes.
Bottom Line
MKSI scores higher overall (55/100 vs 41/100) and 10.6% revenue growth. ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
MKS Instruments Inc
TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA
MKS Instruments, Inc. provides instruments, systems, subsystems, and process control solutions that measure, monitor, deliver, analyze, power, and control critical parameters of manufacturing processes globally. The company is headquartered in Andover, Massachusetts.
Visit Website →Zepp Health Corp
TECHNOLOGY · CONSUMER ELECTRONICS · China
Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.
Compare with Other SCIENTIFIC & TECHNICAL INSTRUMENTS Stocks
Want to dig deeper into these stocks?